Randomized Phase III study of gemcitabine plus S-1 versus gemcitabine plus cisplatin in advanced biliary tract cancer: Japan Clinical Oncology Group Study (JCOG1113, FUGA-BT)

A Phase II selection design trial was conducted to identify the most promising regimen for comparison with standard therapy in chemo-naive patients with unresectable or recurrent biliary tract cancer (JCOG0805). Gemcitabine plus S-1 therapy showed better efficacy than S-1 monotherapy with acceptable...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Jpn J Clin Oncol
Huvudupphovsmän: Mizusawa, Junki, Morizane, Chigusa, Okusaka, Takuji, Katayama, Hiroshi, Ishii, Hiroshi, Fukuda, Haruhiko, Furuse, Junji
Materialtyp: Artigo
Språk:Inglês
Publicerad: Oxford University Press 2016
Ämnen:
Clinical Trial Note
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4886137/
https://ncbi.nlm.nih.gov/pubmed/27025903
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jjco/hyv213
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk